Feng et al. reported that PH20 hyaluronidase and folic acid-modified exosomes can enhance doxorubicin delivery by degrading ECM and inhibit the metastasis of breast cancer caused by hyaluronidase treatment [19]. This evidence concerns the gene SPAM1 and breast cancer.